Abstract:BACKGROUND:Chitooligosaccharides and N-acetylglucosamine are products of high polymer insoluble chitosan via hydrolysis, with the water-solubility.Because of similar molecular structure, chitooligosaccharides and N-acetylglucosamine have anti-oxygenization ability, and can be widely used in prevention and treatment of diabetes and its complications, due to the dissolubility and easy absorption.OBJECTIVE:To observe the effect of different doses of chitooligosaccharides and N-acetylglucosamine on improving antioxidant ability and protecting kidney ability in diabetic mouse induced by streptozotocin.DESIGN, TIME AND SETTING:The randomized controlled animal study was performed at the Biochemistry Laboratory of Ocean University of China from July to September 2008.MATERIALS:Chitooligosaccharides and N-acetylglucosamine were prepared at the Biochemistry Laboratory of Ocean University of China.A total of 81 Wistar rats were randomly and equally assigned into normal control group, negative control group, metformin group, low, moderate and high doses of chitooligosaccharides groups, and low, moderate and high doses of N-acetylglucosamine groups.METHODS:Rats in the normal control group intraperitoneally underwent citrate buffer solution.Rats in the other groups were intraperitoneally treated with streptozotocin solution(65 mg/kg) to establish rat diabetes models.Rats in the low, moderate and high doses of chitooligosaccharides groups, and low, moderate and high doses of N-acetylglucosamine groups were separately subjected to chitooligosaccharides and N-acetylglucosamine(daily 250, 500, 1 500 mg/kg) by gavage.Rats in the normal control and negative control groups underwent the same volume of cold water(10 mL/kg).Rats in the metformin group underwent metformin water solution(200 mg/kg daily) by gavage for successively 60 days.MAIN OUTCOME MEASURES:The following parameters were measured:activities of serum glutathione peroxidase, superoxide dismutase(SOD), malondialdehyde concentration, total antioxidative capacity(T-AOC), index about the kidney function and histopathological examination of the kidney.RESULTS:Chitooligosaccharides and N-acetylglucosamine could improve T-AOC and SOD activity, significantly decrease serum malondialdehyde, urea nitrogen, n-acetyl-β-d-glucosaminidase content, and total protein/creatinine, n-acetyl-β-d-glucosaminidase/creatinine levels in urine.The moderate dose of chitooligosaccharide(500 mg/kg) and low dose of N-acetylglucosamine(250 mg/kg) had the better effects.CONCLUSION:Chitooligosaccharides and N-acetylglucosamine can effectively decrease antioxidant capacity in streptozotocin-induced diabetes rats, and finally result in protection on the kidney.

Effects of N-acetylcysteine on spleen T lymphocyte subgroups and related factors in diabetic rats

Intervention of N-acetylcysteine on Splenocyte Apoptosis and Immune Associated Factors in Rats with Diabetes Mellitus

Protective effect of antioxidant N-acetylcysteine on the retinal nerve tissue of early diabetic rats

Effects of N-acetyl-L-cysteine on Oxidative Stress in Diabetic Mice

Protection of N- acetylcysteine on Kidneys of Diabetic Rats

Effect of N-acetylcysteine and Taurine on Alloxan-Induced Diabetic Rats

Effects of N-acetylcysteine on oxidative stress and the expression of p22phox in lung tissue of diabetic rats

Protective Effects and Mechanism of N-acetylcysteine on Cardiac Injury Induced by Ischemia/reperfusion in Diabetic Rats

Hepatoprotective effects of N-acetylcysteine on liver injury by irisin upregulation and oxidative stress reduction in diabetic rats

N-acetylcysteine attenuates myocardial hypertrophy in streptozotocin-induced diabetic rats

Effect of N-acetylcysteine on ischemia/reperfusion-induced cardiocyte apoptosis in diabetic rats

Effects of N-acetylcysteine on Ischemia/reperfusion-Induced Myocardial Injury in Diabetic Rats

Effects of N-acetylcysteine on nicotinamide dinucleotide phosphate oxidase activation and antioxidant status in heart, lung, liver and kidney in streptozotocin-induced diabetic rats.

Effect of N-acetylcysteine on ischemia/reperfusion-induced cardiac dysfunction in different phases of diabetic rats

Effect of N-acetylcysteine on islet cell cultured with high glucose

The experimental study of antioxidant N-acetylcysteine attenuates the reduction of Brg1 protein expression in the myocardium of type 1 biabetic rats

Effects of chitooligosaccharides and its derivatives on antioxygenization and renal function in experimental diabetes rats

Effects of N-acetylcysteine on caveolin-3 expression during myocardial ischemia-reperfusion in diabetic rats

Effects of Antioxidant N-Acetylcysteine on Caveolin-3/eNOS/NO Signaling Pathway in Early Diabetic Rats

In Vitro Inhibitory Effects of Hyperbaric Oxygen on Function of Rat Splenic Lymphocyte and Preventive Effect of N-acetylcysteine

Protection of N-acetylcysteine on alcoholic liver injury rats